New Risk-Benefit Framework Aims to Accelerate Precision Oncology Trial Enrollment Using Local Biomarker Tests
A working group published a risk-based framework in Nature Health Sciences to help sponsors evaluate local biomarker tests for oncology clinical trial enrollment.
